Product Information

ADDERALL XR 30 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8082 per EA under NDC 54092039101. Its NADAC has been published 657 times since Nov 28, 2013.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

54092039101

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021303

On Market Since

10/11/2001

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for ADDERALL XR 30 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 2.0%. The table below summarizes its recorded NADAC range and movement.

Current price$6.8082 per EA
All-time high$6.9503 (Jul 16, 2014)
All-time low$6.8082 (Jun 17, 2026)
52-week high$6.8203
52-week low$6.8082
Median price$6.8435
Average price$6.8578
Largest weekly change-0.7% (Jan 18, 2017)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.0%

1Y

-0.2%

3Y

-0.3%

5Y

-0.3%

All

-2.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 92%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of ADDERALL XR 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 30 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8082 per EA (NDC 54092039101), effective Jun 24, 2026.

How has the price of ADDERALL XR 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ADDERALL XR 30 MG CAPSULE has declined 2.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ADDERALL XR 30 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ADDERALL XR 30 MG CAPSULE has ranged from a low of $6.8082 (Jun 17, 2026) to a high of $6.9503 (Jul 16, 2014), with a median of $6.8435 per EA.

Are there cheaper alternatives to ADDERALL XR 30 MG CAPSULE?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 30 MG CAP, is $0.5227 per EA — about 92% below ADDERALL XR 30 MG CAPSULE.

Who manufactures ADDERALL XR 30 MG CAPSULE?

ADDERALL XR 30 MG CAPSULE (NDC 54092039101) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.